10/4001/15 - Cost effective treatments and diagnostic approaches for people with schizophrenia within the NHS
Research type: Primary Research
Start date: March 2011
Publication date: September 2014
Cost: £399,896.00
Contractor: University of Nottingham
Publications
- Benzodiazepines for psychosis-induced aggression or agitation (in the Cochrane Library via Wiley Online)
- Chlorpromazine versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia (PDF File, 2.6 MB). DOI: 10.1002/14651858.CD010631.pub2.
- Cognitive behavioural therapy (brief versus standard duration) for schizophrenia (in the Cochrane Library via Wiley Online)
- Depot fluphenazine decanoate and enanthate for schizophrenia (in the Cochrane Library via Wiley Online)
- Family intervention (brief) for schizophrenia (in the Cochrane Library via Wiley Online)
- First Rank symptoms for schizophrenia (PDF File, 933.2 KB). DOI: 10.1002/14651858.CD010653.pub2
- Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders(in the Cochrane Library via Wiley Online)
- Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia (in the Cochrane Library via Wiley Online)
- Flupenthixol versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- Fluphenazine (oral) versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia (in the Cochrane Library via Wiley Online)
- Fluphenazine decanoate (depot) and enanthate for schizophrenia (PDF File, 2.5 MB). DOI: 10.1002/14651858.CD000307.pub2
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (PDF File, 1.2 MB). DOI: 10.1002/14651858.CD010832.pub2
- Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) (in the Cochrane Library via Wiley Online)
- Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia(in the Cochrane Library via Wiley Online)
- Haloperidol versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- Intermittent drug techniques for schizophrenia (in the Cochrane Library via Wiley Online)
- Length of hospitalisation for people with severe mental illness (in the Cochrane Library via Wiley Online)
- Pericyazine for schizophrenia (in the Cochrane Library via Wiley Online)
- Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia (in the Cochrane Library via Wiley Online)
- Perphenazine for schizophrenia (PDF File, 5.2 MB). DOI: 10.1002/14651858.CD003443.pub3
- Pimozide for schizophrenia or related psychoses (in the Cochrane Library via Wiley Online)
- Psychoeducation (brief) for people with serious mental illness (PDF File, 1.2 MB). DOI: 10.1002/14651858.CD010823.pub2
- Risperidone (depot) for schizophrenia (PDF File, 2.3 MB). DOI: 10.1002/14651858.CD004161.pub2
- Sulpiride versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- Supportive therapy for schizophrenia (PDF File, 2.4 MB). DOI: 10.1002/14651858.CD004716.pub4.
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia (in the Cochrane Library via Wiley Online)
- Trifluoperazine versus placebo for schizophrenia (in the Cochrane Library via Wiley Online)
- User-held personalised information for routine care of people with severe mental illness (in the Cochrane Library via Wiley Online)
- Voxel-based morphometry for separation of schizophrenia (PDF File, 513.5 KB). DOI: 10.1002/14651858.CD011021.pub2
- Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses(in the Cochrane Library via Wiley Online)
- Zuclopenthixol versus placebo for schizophrenia (PDF File, 423.9 KB). DOI: 10.1002/14651858.CD010598.pub2.